Systemic Sclerosis: Emerging Biologics Ahead
Systemic Sclerosis, also known as Scleroderma, is a chronic autoimmune disease marked by abnormal connective tissue growth. This condition results in skin thickening, fibrosis of internal organs, and damage to blood vessels. It can severely affect the skin, lungs, heart, kidneys, and diges
